Cost-effectiveness of biomarker testing for treatment choices in advanced non-small cell lung carcinoma: impact of diagnostic strategies and their turnaround times

Sandrine Loubière, Fabrice Barlesi, Pascale Missy, Franck Morin, Pascal Auquier, Jacques Cadranel
  • European Respiratory Journal, June 2018, European Respiratory Society (ERS)
  • DOI: 10.1183/13993003.00844-2018
The author haven't yet claimed this publicationThe author haven't yet claimed this publication
Read Publication

http://dx.doi.org/10.1183/13993003.00844-2018

In partnership with: